SCHEMBL2255104

SCHEMBL2255104

O=C(O)c1ccc(-c2ccc(F)cc2)cc1C=Cc1ccc2cccc(O)c2c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCL2L1 Q07817 1/20 0.67
▸ BAD Q92934 1/20 0.67
▸ CYP1B1 Q16678 2/20 0.42
▸ GRIN2D O15399 1/20 0.42
▸ GRIN2A Q12879 1/20 0.42
▸ GRIN2B Q13224 1/20 0.42
▸ GRIN2C Q14957 1/20 0.42
▸ CYP1A1 P04798 1/20 0.40
▸ RELA Q04206 1/20 0.39
▸ PTPN1 P18031 3/20 0.39
▸ HNF4A P41235 2/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ LCK P06239 1/20 0.38
▸ ACMSD Q8TDX5 3/20 0.38
▸ PTPN2 P17706 1/20 0.38
▸ PTPN6 P29350 1/20 0.38
▸ DHODH Q02127 1/20 0.38
▸ APP P05067 3/20 0.38
▸ MCL1 Q07820 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2255098 1.00 BCL2L1 (0.67) BCL2L1BADCYP1B1GRIN2DGRIN2A
SCHEMBL2251560 0.91 BCL2L1 (0.67) BCL2L1BADGRIN2DGRIN2AGRIN2B
SCHEMBL2251565 0.91 BCL2L1 (0.67) BCL2L1BADGRIN2DGRIN2AGRIN2B
SCHEMBL2251156 0.89 BCL2L1 (0.67) BCL2L1BADCYP1B1CYP1A1RELA
SCHEMBL2251163 0.89 BCL2L1 (0.67) BCL2L1BADCYP1B1CYP1A1RELA
SCHEMBL2253922 0.84 BCL2L1 (0.70) BCL2L1BADCYP1B1RELAPTPN1
SCHEMBL2253926 0.84 BCL2L1 (0.70) BCL2L1BADCYP1B1RELAPTPN1
SCHEMBL2256047 0.83 BCL2L1 (0.51) BCL2L1BADCYP1B1GRIN2DGRIN2A
SCHEMBL2256052 0.83 BCL2L1 (0.51) BCL2L1BADCYP1B1GRIN2DGRIN2A
SCHEMBL2257657 0.82 BCL2L1 (0.64) BCL2L1BADGRIN2DGRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904047-B1 APOPTOSIS PROMOTERS ABBOTT LAB (US) 2013-01-02 — — EP disclosed
US-7989656-B2 Biaryl carboxylic acid apoptosis promoters ABBOTT LABORATORIES (US) 2011-08-02 — — US disclosed
US-20100234456-A1 APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2010-09-16 — — US disclosed
US-7750004-B2 Apoptosis promoters ABBOTT LABORATORIES (US) 2010-07-06 — — US disclosed
US-20070135392-A1 Apoptosis promoters ABBVIE INC. 2007-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234456-A1 APOPTOSIS PROMOTERS MCL1, BAX, BCL2 BCL2L1 5/4885BAD 11/4885CYP1B1 3775/4885
US-20070135392-A1 Apoptosis promoters MCL1, BAX, BCL2 BCL2L1 5/4885BAD 11/4885CYP1B1 3775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback